Evaluation of Benztropine for Cocaine Craving - 2
Completed · Phase 2
Conditions studied: Cocaine-Related Disorders
In brief
The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues.
Key facts
- Study ID
- NCT00000333
- Run by
- National Institute on Drug Abuse (NIDA)
- People needed
- 0
- Starts
- 2001-05-01
- Expected to finish
- 2003-04-01
- Last updated by the study team
- 2017-02-24
Who can join
Age: 22 and older, up to 48. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Washington DC VA — Washington D.C., District of Columbia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.